Navigation Links
Botox for children with neurological impairments

Botox may be used to treat the problem of severe drooling by children suffering from neurological conditions// like cerebral palsy.

Children suffering from cerebral palsy and other similar diseases have no cognition and hence do not have the control over the salivary reflex. This condition often leads to sores, and other physical discomfort apart from being a constant problem for parents or people who are taking care of them.

Researchers of Hospital for Sick Children, Toronto, had used Botox injections, which are guided with the help of the ultrasound into the salivary glands, to control the drooling.

The results of the trials showed that 70% of the procedures have been successful, with children showing little to major improvement in their drooling conditions. The dosage of Botox injections however is dependent on the condition and requirement of each of the children. However, the researchers feel the higher the dosage used and more in frequency, the better results are seen.

This may be one of the first non-invasive successful treatments for the cause, as often surgery is required to treat severe drooling, and that too may not be successful always.

The scientists will be presenting their reports at American Roentgen Ray Society Annual Meeting in New Orleans, US.

Reference: EurekAlert news release, May 2005

Page: 1

Related medicine news :

1. New antiperspirant in action - Botox does the difference
2. New Research Has Found Another Use For Botox
3. Yet Another Use For Botox
4. Botox Found To Be Effective for Voice Tremors
5. Botox Relieves Neuralgic Pain
6. Botox Can Be a Competent Painkiller
7. Treatment Resistant Tumors Can Be Targeted Better Using Botox
8. Botox Treatment Now With A Lesser Dose And Increased Safety
9. Enlarged Prostate Might Be Relieved with Botox injections
10. Muslims in Malaysia Banned from Using Botox
11. Botox Minimizes Facial Scarring
Post Your Comments:

(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: